Crossmark

Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

Published Online: 2024-10-23

Published Print: 2024-12

Authors

Lee, Benjamin J. https://orcid.org/0000-0002-1678-1345
Griffin, Shawn P. https://orcid.org/0000-0002-3818-2490
Doh, Jean https://orcid.org/0000-0003-2737-5243
Ciurea, Stefan O. https://orcid.org/0000-0001-8597-3271
Jeyakumar, Deepa https://orcid.org/0000-0002-8822-1814
Kongtim, Piyanuch https://orcid.org/0000-0003-2130-7645
Naqvi, Kiran https://orcid.org/0000-0002-5511-6153
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 8 September 2024

Accepted: 14 October 2024

First Online: 23 October 2024

Declarations

:

: This research was approved by the University of California Irvine Institutional Review Board (IRB# 3397) and a waiver of informed consent was granted. All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and Good Clinical Practice standards by the University of California Irvine.

: The authors declare no competing interests.

Document is current